Cargando…
Association of the DNMT3B -579G>T Polymorphism with Risk of Thymomas in Patients with Myasthenia Gravis
Increasing evidence suggests a contribution of epigenetic processes in promoting cancer and autoimmunity. Myasthenia gravis (MG) is an autoimmune disease mediated, in approximately 80% of the patients, by antibodies against the nicotinic acetylcholine receptor (AChR+). Moreover, epithelial tumours (...
Autores principales: | Coppedè, Fabio, Ricciardi, Roberta, Denaro, Maria, De Rosa, Anna, Provenzano, Carlo, Bartoccioni, Emanuela, Baggiani, Angelo, Lucchi, Marco, Mussi, Alfredo, Migliore, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834310/ https://www.ncbi.nlm.nih.gov/pubmed/24260492 http://dx.doi.org/10.1371/journal.pone.0080846 |
Ejemplares similares
-
Gene-Specific Methylation Analysis in Thymomas of Patients with Myasthenia Gravis
por: Lopomo, Angela, et al.
Publicado: (2016) -
Investigation of MLH1, MGMT, CDKN2A, and RASSF1A Gene Methylation in Thymomas From Patients With Myasthenia Gravis
por: Coppedè, Fabio, et al.
Publicado: (2020) -
Thymoma‐associated myasthenia gravis: Clinical features and predictive value of antiacetylcholine receptor antibodies in the risk of recurrence of thymoma
por: De Rosa, Anna, et al.
Publicado: (2020) -
Multiple Thymoma with Myasthenia Gravis
por: Seo, Dong Hyun, et al.
Publicado: (2017) -
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients
por: Basile, Umberto, et al.
Publicado: (2018)